{"status": "Ok", "redirect_url": "https://www.businesswire.com/news/home/20260328205340/en/Arrowhead-Pharmaceuticals-Presents-New-Long-Term-Efficacy-and-Safety-Data-for-Plozasiran-Across-a-Spectrum-of-Hypertriglyceridemia-at-the-American-College-of-Cardiology%E2%80%99s-75th-Annual-Scientific-Session-and-Expo", "message": "News view counter 632044 successfully enlarged"}